Aes-103

Aes-103

SCHEMBL14809554

CCOC(C)OCC.O=Cc1ccc(CO)o1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.67
TSHR P16473 1/20 0.67
MAPT P10636 5/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KDM4E B2RXH2 3/20 0.39
HSP90AA1 P07900 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
POLB P06746 3/20 0.39
HPGD P15428 3/20 0.39
TP53 P04637 2/20 0.39
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
STAT1 P42224 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8586891 0.85 ALDH1A1 (0.45) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL9256544 0.84 ALDH1A1 (0.71) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL278332 0.84 ALDH1A1 (0.76) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL28744511 0.84 ALDH1A1 (0.81) ALDH1A1TSHRMAPTNPC1RAB9A
SCHEMBL20496958 0.84 ALDH1A1 (0.44) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL17513182 0.84 ALDH1A1 (0.88) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL31307749 0.82
Aes-103 SCHEMBL4307459 0.81 ALDH1A1 (0.71) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL3053025 0.80 ALDH1A1 (0.69) ALDH1A1TSHRMAPTNPC1RAB9A
Aes-103 SCHEMBL1248422 0.80 ALDH1A1 (0.96) ALDH1A1TSHRMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140357878-A1 METHOD OF PRODUCING 5-HYDROXYMETHYLFURFURAL FROM CARBOHYDRATES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-12-04 US claimed
WO-2013043131-A1 METHOD OF PRODUCING 5-HYDROXYMETHYLFURFURAL FROM CARBOHYDRATES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-03-28 WO claimed
US-10301275-B2 Sweet taste modulators ALTRIA CLIENT SERVICES LLC (US) 2019-05-28 US disclosed
US-20180265487-A1 SWEET TASTE MODULATORS ALTRIA CLIENT SERVICES LLC (US) 2018-09-20 US disclosed
US-20140357878-A1 METHOD OF PRODUCING 5-HYDROXYMETHYLFURFURAL FROM CARBOHYDRATES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2014-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140357878-A1 METHOD OF PRODUCING 5-HYDROXYMETHYLFURFURAL FROM CARBOHYDRATES ADH1C, ADH5, ADH1A ALDH1A1 68/4885TSHR 1770/4885MAPT 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.